VeriSign Operating Cash Flow decreased by 5.9% to $272.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.5%, from $291.30M to $272.40M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 7.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $142.50M | $260.10M | $206.30M | $207.10M | $144.90M | $262.20M | $216.90M | $259.00M | $145.30M | $245.30M | $204.20M | $257.30M | $160.40M | $253.40M | $231.50M | $291.30M | $202.50M | $307.70M | $289.60M | $272.40M |
| QoQ Change | — | +82.5% | -20.7% | +0.4% | -30.0% | +81.0% | -17.3% | +19.4% | -43.9% | +68.8% | -16.8% | +26.0% | -37.7% | +58.0% | -8.6% | +25.8% | -30.5% | +52.0% | -5.9% | -5.9% |
| YoY Change | — | — | — | — | +1.7% | +0.8% | +5.1% | +25.1% | +0.3% | -6.4% | -5.9% | -0.7% | +10.4% | +3.3% | +13.4% | +13.2% | +26.2% | +21.4% | +25.1% | -6.5% |